Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 82868-029

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 82868-029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (82868 029 30 Rev A 11 23)

Label (82868 029 30 Rev A 11 23)
Atorvastatin Calcium 40 mg film-coated tablets label showing a package of 30 tablets. The label includes dosage instructions to see package insert and storage conditions specifying 20°-25°C with allowed excursions. The labeler is Northwind Health Company, LLC, and the product NDC is 82868-029.*
FDA Label Image

Figure-01 (Figure 01)

Figure-01 (Figure 01)
A line graph depicting cumulative incidence percentage over time in years comparing Atorvastatin and Placebo groups. The graph shows lower cumulative incidence for Atorvastatin versus Placebo, with statistical values including hazard ratio and p-value indicated below the graph.*
FDA Label Image

Figure-02 (Figure 02)

Figure-02 (Figure 02)
A cumulative hazard graph comparing Atorvastatin versus placebo over a 4-year follow-up period. The x-axis represents time in years to the first primary endpoint, and the y-axis shows cumulative hazard percentage. The Atorvastatin curve lies consistently below the placebo curve, with an indicated hazard ratio (HR) of 0.63 (0.48-0.83) and a p-value of 0.001, suggesting a statistically significant difference between the groups.*
FDA Label Image

Figure-03 (Figure 03)

Figure-03 (Figure 03)
A line graph comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg. The x-axis represents time to first major cardiovascular endpoint in years (0 to 5), and the y-axis shows subjects (%) experiencing the event (0 to 0.2). The 10 mg group is represented by a dashed line, and the 80 mg group by a solid line, with a hazard ratio (HR) of 0.78 and p-value of 0.0002 indicated on the graph.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure of atorvastatin calcium, displaying the molecular arrangement of the atorvastatin molecule complexed with calcium ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.